Scarica l'app Stockscreener
52.73
2.64%
-1.43
Dopo l'orario di chiusura:
52.73
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$54.16
Aprire:
$54.335
Volume 24 ore:
3.99M
Relative Volume:
1.42
Capitalizzazione di mercato:
$13.02B
Reddito:
$4.03B
Utile/perdita netta:
$789.50M
Rapporto P/E:
15.83
EPS:
3.33
Flusso di cassa netto:
$1.15B
1 W Prestazione:
-9.21%
1M Prestazione:
-13.36%
6M Prestazione:
-33.08%
1 anno Prestazione:
-31.11%
Intervallo 1D:
$52.69
$54.34
Intervallo di 1 settimana:
$52.12
$58.59
Portata 52W:
$52.12
$84.67
Hologic Inc Stock (HOLX) Company Profile
Nome
Hologic Inc
Settore
Industria
Telefono
(508) 263-2900
Indirizzo
250 CAMPUS DRIVE, MARLBOROUGH, MA
Confronta HOLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
52.73 | 13.02B | 4.03B | 789.50M | 1.15B | 3.33 |
|
ISRG
Intuitive Surgical Inc
|
531.82 | 184.23B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
167.00 | 58.65B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
97.38 | 47.15B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
240.66 | 35.34B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
81.57 | 16.25B | 3.90B | 392.30M | 288.10M | 1.95 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-03 | Downgrade | Argus | Buy → Hold |
| 2025-02-06 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Downgrade | Needham | Buy → Hold |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-12-10 | Reiterato | Needham | Buy |
| 2024-10-01 | Downgrade | Citigroup | Buy → Neutral |
| 2024-06-27 | Iniziato | Stephens | Overweight |
| 2024-04-03 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-07-14 | Aggiornamento | Needham | Hold → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-07-20 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-07-20 | Iniziato | UBS | Neutral |
| 2022-07-18 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Downgrade | Needham | Buy → Hold |
| 2020-11-05 | Reiterato | Needham | Buy |
| 2020-06-30 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2020-06-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Reiterato | Needham | Buy |
| 2020-04-30 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Reiterato | Needham | Buy |
| 2019-05-02 | Reiterato | Needham | Buy |
| 2019-01-31 | Reiterato | Needham | Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Iniziato | UBS | Neutral |
| 2018-09-13 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Hologic Inc Borsa (HOLX) Ultime notizie
Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries - AboutLawsuits.com
Hologic (HOLX) Faces Lower Price Target Amidst Maintained Rating | HOLX Stock News - GuruFocus
Lobbying Update: $210,000 of HOLOGIC INC. lobbying was just disclosed - Nasdaq
Mizuho cuts Hologic stock price target to $65 from $75 By Investing.com - Investing.com India
Mizuho cuts Hologic stock price target to $65 from $75 - Investing.com
Hologic (HOLX) Price Target Reduced by Morgan Stanley Analyst | HOLX Stock News - GuruFocus
Morgan Stanley Cuts Price Target on Hologic to $65 From $77, Keeps Equalweight Rating - marketscreener.com
Hologic drops as tariffs and geopolitics lead to guidance cut - MSN
Hologic outlines Q3 2025 revenue target of $1B-$1.01B amid breast health recovery - MSN
Hologic Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Hologic, Inc. (NASDAQ:HOLX) Q2 2025 Earnings Call Transcript - Insider Monkey
Breaking Down Hologic: 10 Analysts Share Their Views - Benzinga
Hologic Inc. stock underperforms Friday when compared to competitors - MarketWatch
Hologic (HOLX) Price Target Lowered by RBC Capital | HOLX Stock News - GuruFocus
Hologic (HOLX) Target Price Lowered by Raymond James | HOLX Stock News - GuruFocus
Hologic sees drop in sales and tariff impact on stock prices - Radiology Business
Leerink Partners Adjusts Hologic Price Target to $60 From $65 - marketscreener.com
Jefferies Adjusts Hologic Price Target to $65 From $78 - marketscreener.com
Hologic Enters Oversold Territory (HOLX) - Nasdaq
Hologic falls after 2025 profit forecast cut - TradingView
Hologic stock price target cut to $65 by Jefferies - Investing.com Nigeria
Evercore ISI Group Lowers Price Target for Hologic (HOLX) to $62 - GuruFocus
Evercore ISI Group Lowers Price Target for Hologic (HOLX) to $62 | HOLX Stock News - GuruFocus
Hologic (HOLX) Shares Plunge 18% After Revised Earnings Outlook - GuruFocus
Hologic (HOLX): Price Target Reduced Amid Tariff Pressures | HOL - GuruFocus
RBC Cuts Price Target on Hologic to $70 From $75, Keeps Sector Perform Rating - marketscreener.com
Hologic (HOLX) Receives Hold Rating from Needham Analyst | HOLX Stock News - GuruFocus
Hologic stock drops after guidance cut (HOLX:NASDAQ) - Seeking Alpha
HOLOGIC INC SEC 10-Q Report - TradingView
Hologic Q2 Earnings & Revenues Top, '25 EPS View Lowered, Stock Down - Nasdaq
Hologic Inc (HOLX) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth - Yahoo Finance
Hologic Inc (HOLX) Q2 Earnings: Revenue Hits $1,005.3M, Non-GAAP EPS at $1.03, Surpassing Estimates - GuruFocus
Hologic Exceeds Revenue Guidance Amid Challenges - TipRanks
Hologic: Fiscal Q2 Earnings Snapshot - MySA
Hologic Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Hologic Q2’25 slides: Mixed results amid long-term growth strategy - Investing.com India
Earnings call transcript: Hologic beats Q1 2025 EPS forecast amid stock dip - Investing.com Nigeria
Medical equipment maker Hologic lowers annual profit forecast on tariff uncertainty - TradingView
Hologic Posts Q2 Loss On Impairment Charges Despite Stable Revenue - Nasdaq
Hologic Announces Financial Results for Second Quarter of Fiscal 2025 - BioSpace
Hologic beats Q2 estimates, lowers full-year outlook By Investing.com - Investing.com South Africa
Hologic’s (NASDAQ:HOLX) Q1 Earnings Results: Revenue In Line With Expectations But Quarterly Revenue Guidance Significantly Misses Expectations - Yahoo Finance
Hologic (HOLX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo
Hologic (HOLX) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
HOLOGIC Earnings Results: $HOLX Reports Quarterly Earnings - Nasdaq
Hologic earnings beat by $0.01, revenue topped estimates - Investing.com Canada
Earnings Flash (HOLX) HOLOGIC INC. Reports Q2 Revenue $1.01B, vs. FactSet Est of $1.00B - marketscreener.com
GYN Surgical Division Likely to Drive Hologic's Q2 Earnings - MSN
Here's What to Expect From Hologic’s Next Earnings Report - MSN
Tower Consultants Search Places Senior Talent Leader at Hologic - Hunt Scanlon Media
Press Release Distribution & PR Platform - ACCESS Newswire
Hologic Inc Azioni (HOLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):